Chemed Corp

Chemed Corp(CHE)股票分析

$512.380

-3.023 (-0.59%)收盤時

Loading chart…
最高
520.885
開盤
518.790
成交量加權均價
514.32
成交量
89.40K
市值
8.22B
最低
509.705
成交金額
45.98M
企業價值/稅息折舊攤銷前利潤(TTM)
15.66

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.

AI 分析 of Chemed Corp (CHE)

買進

Chemed Corp is a good buy right now due to its current price of $512.38, which is below the median analyst price target of $549, indicating a potential upside of 7.1%. Additionally, the company has shown a strong year-to-date change of +20.90%, reflecting solid performance. However, a risk to consider is the insider selling activity, where an executive sold 1,000 shares, reducing holdings by 7%, which could signal caution among insiders.

分析師評級(4)

上檔空間 +6.82%
持有
1 買進
3 持有
0 賣出
目前: 512.38
最低
475.00
平均
547.33
最高
595.00

UBS

2026-09-25

目標價

$650

買進

Oppenheimer

2026-07-31

目標價

$590

優於大盤

RBC Capital

2026-07-30

目標價

$548

Sector Perform

BofA

2026-07-09

目標價

$510

中性

RBC Capital

2026-04-27

目標價

$436

Sector Perform

估值指標

Chemed Corp(CHE)目前預期本益比為 18.18,5 年平均預期本益比為 22.80。

預期本益比

低估
5 年均值 P/E
22.80
目前P/E
18.18
高估
25.62
低估
19.97

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
15.66
目前EV/EBITDA
15.66
高估
17.42
低估
13.90

預期股價營收比

低估
5 年均值 P/S
3.09
目前P/S
2.33
高估
3.63
低估
2.56

Alphio AI 對 CHE 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%CHE

$709.68

情境價格

基

基準

基準 · 50%CHE

$700.04

情境價格

悲

悲觀

悲觀 · 25%CHE

$601.39

情境價格

持有 CHE 的大戶

V

Van Berkom and Associates Inc.

+ 持有CHE

+0.24%

3個月報酬率

B

Boston Trust Walden National Association

+ 持有CHE

-2.86%

3個月報酬率

C

Copeland Capital Management, LLC

+ 持有CHE

-7.87%

3個月報酬率

E

Eversept Partners, L.P.

+ 持有CHE

-9.49%

3個月報酬率

事件時間軸

2026-08-06 (ET)

12:00:00

Chemed Corporation Declares Quarterly Cash Dividend of $0.70 per Share

2026-07-28 (ET)

16:30:00

Company Revises Guidance, Expected EPS at $24.34

16:30:00

Company Reports Q2 Revenue of $673.25M, Beating Consensus

2026-04-23 (ET)

16:30:00

VITAS Raises 2026 Earnings Guidance to $24.00 to $24.75 per Share

資訊

CHE 常見問題 —— 由 Alphio AI 解答

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

Chemed Corp is a good buy right now due to its current price of $512.38, which is below the median analyst price target of $549, indicating a potential upside of 7.1%. Additionally, the company has shown a strong year-to-date change of +20.90%, reflecting solid performance. However, a risk to consider is the insider selling activity, where an executive sold 1,000 shares, reducing holdings by 7%, which could signal caution among insiders.

4 analysts cover CHE: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 547.33.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易